FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/10/059358 [Registered on: 31/10/2023] Trial Registered Prospectively
Last Modified On: 26/10/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Process of Care Changes 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A trial comparing whether giving less intravenous fluid than usual in mechanically ventilated children is associated with better outcomes. 
Scientific Title of Study   Impact of protocolized restrictive versus liberal/usual maintenance fluid strategy on fluid overload among mechanically ventilated children: an open-label randomized trial (ReLiSCh-II trial) 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sujith Mathew John 
Designation  Junior Resident 
Affiliation  Postgraduate Institute of Medical Education and Research PGIMER 
Address  Dr. Sujith Mathew John, Junior Resident, Advanced Pediatric Centre, Post-graduate Institute of Medical Education and Research PGIMER, Chandigarh CHANDIGARH

Chandigarh
CHANDIGARH
160012
India 
Phone  8825563493  
Fax    
Email  sujithmathewjohn@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sujith Mathew John 
Designation  Junior Resident 
Affiliation  Postgraduate Institute of Medical Education and Research PGIMER 
Address  Dr. Sujith Mathew John, Junior Resident, Advanced Pediatric Centre, Post-graduate Institute of Medical Education and Research PGIMER, Chandigarh CHANDIGARH

Chandigarh
CHANDIGARH
160012
India 
Phone  8825563493  
Fax    
Email  sujithmathewjohn@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sujith Mathew John 
Designation  Junior Resident 
Affiliation  Postgraduate Institute of Medical Education and Research PGIMER 
Address  Dr. Sujith Mathew John, Junior Resident, Advanced Pediatric Centre, Post-graduate Institute of Medical Education and Research PGIMER, Chandigarh CHANDIGARH

Chandigarh
CHANDIGARH
160012
India 
Phone  8825563493  
Fax    
Email  sujithmathewjohn@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr Suresh Kumar 
Address  Dr. Suresh Kumar, Associate Professor, Department of Pediatrics, Advanced Pediatric Centre, Post-graduate Institute of Medical Education and Research PGIMER, Chandigarh CHANDIGARH 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Suresh Kumar  Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh  Pediatric Intensive Care Unit, Advanced Pediatric Centre, Postgraduate Institute of Medical Education and Research, Chandigarh - 160012
Chandigarh
CHANDIGARH 
9855373969

sureshangurana@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee (Intramural), Postgraduate Institute of Medical Education and Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J969||Respiratory failure, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Liberal (Usual) maintenance fluid group  70-80% maintenance fluids as calculated by Holliday-Segar formula. Duration: 5 days from enrollment. 
Intervention  Protocolized restrictive maintenance fluid group  40-50% maintenance fluids as calculated by Holliday-Segar formula. In addition, children with Fluid overload % (FO%) more than 10% will be started on Furosemide infusion at 0.1 mg/kg/hour until FO% less than 10%. Duration: 5 days from enrollment. 
 
Inclusion Criteria  
Age From  3.00 Month(s)
Age To  12.00 Year(s)
Gender  Both 
Details  All children between the age group of 3 months to 12 years who are mechanically ventilated (with anticipated mechanical ventilation for ≥48 hours) and have been haemodynamically stable for 6 hours prior to enrolment (no requirement for fluid boluses or increase in vasoactive drugs over the past 6 hours). 
 
ExclusionCriteria 
Details  1. Haemodynamically unstable children (requirement of fluid boluses or increase in vasoactive drugs over the past 6 hours)
2. Diarrhoea with dehydration
3. Acute kidney injury
4. Need of renal replacement therapy at admission
5. Known congenital or acquired cardiac disease
6. Chronic liver, lung, or kidney disease
7. Inborn errors of metabolism
8. Diabetic ketoacidosis
9. Known syndrome of inappropriate ADH secretion (SIADH), cerebral salt wasting (CSW) or diabetes insipidus
10. Consent refusal
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Proportion with fluid overload percentage (FO%) >10%   Within first 5 days of enrollment 
 
Secondary Outcome  
Outcome  TimePoints 
Daily fluid overload% (FO%) till day 5  Day 1 to Day 5 
IVC diameter and IVC variability index  48 hours 
N-terminal pro-Brain natriuretic peptide (NT-proBNP)  48 hours 
Safety parameters – requirement for fluid boluses, change in fluid prescription, vasoactive agents and daily Vasoactive Inotrope Score (VIS).  Day 1 to Day 5 
Ventilator Free Days (VFDs)   Day 28 
PICU Free Days (PFDs)  Day 28 
Mortality  Day 28 
 
Target Sample Size   Total Sample Size="130"
Sample Size from India="130" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   06/11/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Fluid overload of >10% has been shown to be associated with adverse outcomes in mechanically ventilated patients. This study is a randomized, open-label trial comparing the impact of protocolized restrictive versus liberal/usual maintenance fluid strategy on fluid overload among mechanically ventilated children. 130 children (3 months-12 years) who are mechanically ventilated for any indication and have been haemodynamically stable for 6 hours prior to enrollment, with none of the exclusion criteria, will be randomized to receive either "Protocolized restrictive" or "Liberal/Usual" maintenance fluids. Children in the protocolized restrictive group will receive 40-50% maintenance fluids with de-resuscitation with Furosemide infusion if fluid overload percentage (FO%) > 10%; Children in the liberal/usual group will receive 70% maintenance fluids as per unit protocol. The primary outcome will be the proportion with FO% > 10% within 5 days after enrollment. Secondary outcomes will be daily FO% till day 5, inferior vena cava (IVC) diameter and IVC variability index at 48 hours, N-terminal pro-brain natriuretic peptide (NT-proBNP) at 48 hours, safety parameters, ventilator free days and PICU-free days at day 28, and mortality in 28 days. 
Close